OA08724A - Treatment of human viral infections by dsRNA combined with viral inhibitors. - Google Patents

Treatment of human viral infections by dsRNA combined with viral inhibitors.

Info

Publication number
OA08724A
OA08724A OA59306A OA59306A OA08724A OA 08724 A OA08724 A OA 08724A OA 59306 A OA59306 A OA 59306A OA 59306 A OA59306 A OA 59306A OA 08724 A OA08724 A OA 08724A
Authority
OA
OAPI
Prior art keywords
viral
treatment
inhibitors
human
dsrna
Prior art date
Application number
OA59306A
Other languages
English (en)
French (fr)
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of OA08724A publication Critical patent/OA08724A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
OA59306A 1987-03-23 1988-03-23 Treatment of human viral infections by dsRNA combined with viral inhibitors. OA08724A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2882387A 1987-03-23 1987-03-23
US07/125,097 US4950652A (en) 1987-03-23 1987-11-25 dsRNAs for combination therapy in the treatment of viral diseases

Publications (1)

Publication Number Publication Date
OA08724A true OA08724A (fr) 1989-03-31

Family

ID=26704119

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59306A OA08724A (fr) 1987-03-23 1988-03-23 Treatment of human viral infections by dsRNA combined with viral inhibitors.

Country Status (21)

Country Link
US (1) US4950652A (en, 2012)
EP (1) EP0286224B1 (en, 2012)
JP (1) JP2656938B2 (en, 2012)
KR (1) KR960013435B1 (en, 2012)
CN (1) CN1049357C (en, 2012)
AU (1) AU1256288A (en, 2012)
CA (1) CA1316832C (en, 2012)
DE (1) DE3876125T2 (en, 2012)
DK (1) DK156688A (en, 2012)
ES (1) ES2066782T3 (en, 2012)
FI (1) FI881305A7 (en, 2012)
GR (1) GR3006340T3 (en, 2012)
HU (1) HUT46542A (en, 2012)
IE (1) IE63823B1 (en, 2012)
IL (1) IL85646A (en, 2012)
NO (1) NO881246L (en, 2012)
NZ (1) NZ223868A (en, 2012)
OA (1) OA08724A (en, 2012)
PH (1) PH23333A (en, 2012)
PT (1) PT87039B (en, 2012)
RU (1) RU2016572C1 (en, 2012)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130206A (en) * 1980-07-07 2000-10-10 Hem Research, Inc. Treating viral infections associated with chronic fatigue with dsRNA
US9309574B1 (en) 1984-08-22 2016-04-12 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Molecular cloning of HIV-1 from immortalized cell lines
US5906980A (en) * 1987-07-17 1999-05-25 Hem Research Inc. Treatment of hepatitis with mismatched dsRNA
US5091374A (en) * 1987-07-17 1992-02-25 Hem Research Inc. Double-stranded RNA correction of abnormalities in circulating immune complexes and monocyte function
US5712257A (en) * 1987-08-12 1998-01-27 Hem Research, Inc. Topically active compositions of mismatched dsRNAs
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
US4960592A (en) * 1989-04-17 1990-10-02 Lanocare Laboratories Lanolin and lanolin oil skin treatment composition
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6703418B2 (en) * 1991-02-26 2004-03-09 Unimed Pharmaceuticals, Inc. Appetite stimulation and induction of weight gain in patients suffering from symptomatic HIV infection
CA2102221A1 (en) * 1991-04-16 1992-10-17 William Carter Abrogation of viral resistance to nucleoside analogues by double-stranded rnas
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
CA2113573A1 (en) * 1991-07-16 1993-02-04 William Carter Modulation and diagnosis of cytokine dysfunctions
US20030207813A1 (en) * 1996-12-09 2003-11-06 G.D. Searle Retroviral protease inhibitor combinations
US5766582A (en) * 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
CN1192688A (zh) * 1995-06-07 1998-09-09 特莱默里斯公司 联合疗法治疗hiv和其它病毒性感染
US5834443A (en) * 1996-05-21 1998-11-10 Masiello; Domenick J. Composition and method for treating herpes simplex
RU2123339C1 (ru) * 1996-06-18 1998-12-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Противовирусное средство
CA2278158A1 (en) * 1997-01-14 1998-07-16 Guangyi Wang Cytokine related treatments of disease
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
LT4475B (lt) * 1997-02-28 1999-02-25 Virmantas Stunžėnas Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
AR013269A1 (es) * 1997-08-04 2000-12-13 Scras Producto que contiene por lo menos un rna de doble filamento combinado con por lo menos un agente anti-viral, para la utilizacion terapeutica en eltratamiento de una enfermedad viral, en especial de la hepatitis viral
FR2766711B1 (fr) * 1997-08-04 2001-02-02 Sod Conseils Rech Applic Produit comprenant au moins un arn double brin en association avec au moins un devire du 6-benzyluracile pour une utilisation therapeutique simultanee, separee ou etalee dans le temps
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
ES2374290T3 (es) 1998-03-20 2012-02-15 Commonwealth Scientific And Industrial Research Organisation Genes sintéticos y constructos genéticos que comprenden los mismos.
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
FR2776927B1 (fr) * 1998-04-07 2002-07-05 Univ Paris Curie Compositions pour la vectorisation de molecules
CA2361201A1 (en) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
RU2172631C2 (ru) * 1999-10-08 2001-08-27 Государственный научный центр вирусологии и биотехнологии "Вектор" Индуктор интерферона пролонгированного действия
EP1322655B1 (en) 2000-01-14 2007-11-14 The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services Oligodeoxynucleotide and its use to induce an immune response
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
US20080242627A1 (en) * 2000-08-02 2008-10-02 University Of Southern California Novel rna interference methods using dna-rna duplex constructs
DE10100588A1 (de) * 2001-01-09 2002-07-18 Ribopharma Ag Verfahren zur Hemmung der Expression eines Zielgens
EP1229134A3 (en) 2001-01-31 2004-01-28 Nucleonics, Inc Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
US7666674B2 (en) 2001-07-27 2010-02-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
AU2002361468A1 (en) 2001-08-14 2003-03-18 The Government Of The United States Of America As Represented By The Secretary Of Health And Human S Method for rapid generation of mature dendritic cells
CA2470204A1 (en) * 2001-12-14 2003-06-26 William A. Carter Use of dsrnas in strategic therapeutic intervention of highly active antiretroviral therapy
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
WO2003054161A2 (en) 2001-12-20 2003-07-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
EP1478656B1 (en) 2002-02-01 2009-09-16 Life Technologies Corporation Oligonucleotide compositions with enhanced efficiency
ES2734652T3 (es) 2002-04-04 2019-12-11 Zoetis Belgium S A Oligorribonucleótidos inmunoestimulantes que contienen G y U
US8263091B2 (en) 2002-09-18 2012-09-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
US20050137154A1 (en) * 2003-05-16 2005-06-23 Hemispherx Biopharma Treating server acute respiratory syndrome
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections
WO2005007831A2 (en) * 2003-07-18 2005-01-27 Vanderbilt University Compositions of protein mimetics and methods of using same against hiv-1, sars-cov and the like
WO2005014038A1 (ja) * 2003-08-11 2005-02-17 The Research Foundation For Microbial Diseases Of Osaka University 粘膜免疫誘導アジュバントを含む新規ワクチン
RU2272631C2 (ru) * 2004-04-20 2006-03-27 Государственный научный центр вирусологии и биотехнологии "Вектор" (ГНЦ ВБ "Вектор") Синергическая композиция для ингибирования вич
DE202005004135U1 (de) * 2005-03-11 2005-05-19 Klocke Verpackungs-Service Gmbh Mehrkomponentenverpackung mit Applikator
EP2883957A1 (en) 2005-11-25 2015-06-17 Zoetis Belgium S.A. Immunostimmulatory oligoribonucleotides
CN101437534A (zh) * 2006-03-08 2009-05-20 半球生物制药公司 口服干扰素的广谱免疫和抗病毒基因调节作用
US8075877B2 (en) 2006-03-08 2011-12-13 Hemispherx Biopharma Broad spectrum immune and antiviral gene modulation by oral interferon
US20100285115A1 (en) * 2007-10-29 2010-11-11 Cipla Limited Novel Antiretroviral Combination
AU2009215128A1 (en) * 2008-02-15 2009-08-20 Hemispherx Biopharma, Inc. Selective agonist of toll-like receptor 3

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113162B1 (en) * 1982-09-16 1989-07-19 Hem Research, Inc. Anti-proliferative action of dsnras on tumor cells
AP11A (en) * 1985-03-16 1987-12-22 The Wellcome Foundation Ltd Antiviral nucleosides.
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
CN1049357C (zh) 2000-02-16
CN88101606A (zh) 1988-12-28
IL85646A0 (en) 1988-08-31
NZ223868A (en) 1991-02-26
KR960013435B1 (ko) 1996-10-05
EP0286224B1 (en) 1992-11-25
PH23333A (en) 1989-07-14
DE3876125T2 (de) 1993-06-09
FI881305L (fi) 1988-09-24
NO881246D0 (no) 1988-03-21
GR3006340T3 (en, 2012) 1993-06-21
NO881246L (no) 1988-09-26
CA1316832C (en) 1993-04-27
IE63823B1 (en) 1995-06-14
FI881305A7 (fi) 1988-09-24
JPS6425A (en) 1989-01-05
FI881305A0 (fi) 1988-03-18
IL85646A (en) 1993-05-13
DE3876125D1 (de) 1993-01-07
PT87039B (pt) 1992-11-30
DK156688D0 (da) 1988-03-22
AU1256288A (en) 1988-09-22
EP0286224A3 (en) 1988-12-07
US4950652A (en) 1990-08-21
JP2656938B2 (ja) 1997-09-24
IE880839L (en) 1988-09-23
PT87039A (pt) 1988-04-01
RU2016572C1 (ru) 1994-07-30
KR880010777A (ko) 1988-10-24
ES2066782T3 (es) 1995-03-16
HUT46542A (en) 1988-11-28
DK156688A (da) 1988-09-24
EP0286224A2 (en) 1988-10-12

Similar Documents

Publication Publication Date Title
OA08724A (fr) Treatment of human viral infections by dsRNA combined with viral inhibitors.
FI882456L (fi) Human proapolipoprotein a-i expression.
NO884124L (no) Kapasitivt maaleapparat for tomroms-andel.
DE19475001I2 (de) Anthelminthische Wirkstoffkombinationen.
DE3885913D1 (de) Aufbereitung von Alkoxysilanen.
DE3788873D1 (de) Massagegerät.
DE3883966D1 (de) Behandlung durchlässiger membranen.
FI884006L (fi) Hoernfog av vaendraelsar.
FI881862A7 (fi) Ortopedinen sidos.
DE3875192D1 (de) Abgasbehandlung.
DE3875016D1 (de) Therapeutikum zur behandlung von aids.
DK373688A (da) Behandlingsmetode
NO881255L (no) Behandling av fluider.
DK191089D0 (da) Biologisk aktive forbindelser
DE69108357D1 (de) Behandlung von verdünnten säurehaltigen Lösungen.
ES2012433A4 (es) Descafeinizacion de estractos acuosos.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
DE3688625D1 (de) Therapeutische bandage.
NO884062D0 (no) Desinfeksjon av avforminger.
IT8420712A0 (it) Trattamento delle infezioni erpetiche.
DK196588A (da) Forbinding
ZA881639B (en) Treatment of human viral infection by dsrna combined with viral inhibitors
FI884069A7 (fi) Kaksijuosteisen RNA:n puutostilojen diagnoosi ja käsittely.
ES1003219Y (es) Juego-juguete de habilidad.
FI841831A0 (fi) Baeranordning foer urinpaose.